AREDS2 cut AMD progression risk by about 26% - but that is the full six-ingredient formula, in people who already had the disease. What the NIH evidence really shows.
Eye Health
Lutein, zeaxanthin and the AREDS2 trial — what National Eye Institute research shows about eye supplements, macular degeneration and screen strain.